Molecular cloning is a widely used method in biotechnology and molecular biology that enables the manipulation and replication of specific DNA sequences.

Molecular cloning involves the isolation of a gene of interest and its insertion into a suitable vector, which is then introduced into a host organism, allowing the gene to replicate and express within the host system¹.

Molecular cloning has become exceedingly important in genetic research, contributing to advancements in medicine, such as forensic science and prenatal and postnatal diagnosis of hereditary diseases. In agriculture, it helps improve rice crop yields by studying the agronomic features. In environmental science, cloning enzymes like poly(ethylene terephthalate hydrolase (PETase) and mono(2-hydroxyethyl) terephthalate hydrolase (MHETase) from Ideonella sakaiensis, when introduced into fast-growing microbes like Escherichia coli, enhance plastic degradation^2,3,4.

Basic principles of molecular cloning

Molecular cloning aims to produce multiple identical copies of a specific DNA fragment within a host cell and involves several steps, including gene isolation and fragmentation, insertion into a cloning vector, transformation into a host organism, and screening to verify successful replication cloning¹.

DNA isolation and fragmentation: The first step in molecular cloning is the isolation of DNA, where a targeted DNA fragment is extracted from cells. The DNA is then fragmented using restriction enzymes to produce smaller fragments suitable for cloning.

Cloning vectors and their function: Cloning vectors, like plasmids or bacteriophages, are DNA molecules that carry the fragmented DNA into a host organism. These vectors contain replication sequences and often include selectable markers to identify successfully transformed cells.

Host organism transformation: After preparing the vector, the next vital step is transformation, whereby recombinant DNA is introduced into a host organism (typically bacterial, yeast, or mammalian cells). This step allows the host to replicate the recombinant DNA and express the desired gene.

Overview of recombinant DNA creation: The process of recombinant DNA technology begins with the isolation of the target DNA and its fragmentation. These segments are then placed into a cloning vector, which is transferred into a host cell using a process known as transformation. Once within the host, the recombinant DNA replicates, and the transformed cells get selected and cultivated in selective media.

Screening for molecular cloning: Screening methods are used to differentiate the recombinants from the non-recombinants. For example, blue‑white screening is a simple visual assay that separates bacteria (or phage) carrying recombinant plasmids from those with empty vectors. It relies on β‑galactosidase: when the enzyme is functional, it cleaves the chromogenic substrate X‑gal, and the resulting 5‑bromo‑4‑chloro‑3‑hydroxyindole dimerizes and oxidizes to form an indigo‑blue pigment. Colonies with an intact lacZ α‑peptide turn blue, whereas colonies whose lacZ gene is disrupted by an inserted DNA fragment lack enzyme activity and remain white⁵.

Molecular cloning techniques

Various strategies are available for molecular cloning, with the method chosen based on factors such as cost, time efficiency, resource availability, and experimental objectives. Different cloning techniques offer distinct advantages, making certain approaches more suitable for specific types of research and applications than others.

Restriction-enzyme cloning

Principles and process of restriction-enzyme cloning: Restriction-enzyme cloning is one of the classic molecular cloning approaches, which involves the usage of different restriction enzymes to cleave the DNA and insert the vector at a specific site, producing “sticky ends” (5ʹ–3ʹ overhangs) or “blunt ends” (no overhangs) facilitating the alignment of the DNA fragment with the vector. Once properly aligned, T4 DNA ligase catalyzes the formation of phosphodiester bonds between the complementary fragments, resulting in a stable recombinant DNA molecule. This method remains widely used due to its reliability and precision in genetic engineering and recombinant DNA technology⁶.

Advantages and limitations of restriction-enzyme cloning: Restriction-enzyme cloning takes advantage of hundreds of accessible enzymes, most of which are considerably affordable. They cut specific target sequences ranging from 4 to 13 base pairs, yielding predictable endpoints in the DNA pieces. However, it can be time-consuming compared with other cloning techniques.

One‑step digestion–ligation variants accelerate the cloning process yet demand specially designed vectors, limiting cross‑system flexibility. Improved restriction digestion-ligation (IRDL) cloning improves selection by adding a ccdB “suicide” gene, but that requirement confines its use to vectors engineered with this negative‑selection marker⁷.

Thus, advancements in the restriction-enzyme cloning techniques have improved efficiency and cost-effectiveness. For example, pyrite cloning is a new method that combines restriction enzyme digestion and ligation in a single tube using a programmed thermocycler, simplifying DNA insertion into bacterial vectors. It yields about 50% correct colonies, which can be quickly identified by colony PCR or blue-white screening. This technique is flexible, affordable, simple, and efficient compared to traditional cloning approaches^7,8.

Example: Restriction enzyme cloning has been used to produce recombinant insulin and the Hepatitis B vaccine, greatly benefiting public health. These enzymes have also been engineered into artificial nucleases like Zinc-finger and TAL-effector nucleases for gene targeting and therapy. The broad impact of restriction enzymes spans medicine and genetic engineering, such as cutting the lacZ gene via restriction enzyme and insertion of DNA to EcoRI sites, which disrupts beta-galactosidase activity and allowseasy screening of recombinant clones via color assays⁹.

PCR cloning

Overview of PCR-based cloning methods
Polymerase chain reaction (PCR) cloning is different from traditional cloning methods because it takes advantage of PCR to amplify a specific DNA fragment, which is then inserted and ligated into a cloning vector. Being a high-throughput cloning technique, PCR cloning uses Taq DNA polymerase, topoisomerase I, and T4 DNA ligase for amplification⁶.

Applications of PCR cloning in molecular biology
PCR cloning is essential in producing a large quantity of specific DNA sequences, allowing researchers to study genes, mutations, and regulatory regions. This method is widely applied in gene expression analysis, gene editing, and the cloning of DNA fragments for further structural and functional studies. Its high specificity, efficiency, and capability to amplify target sequences make it an essential tool in molecular biology and genetic research.

As an example of PCR-based cloning, the tdTomato fluorescent gene was amplified using primers containing embedded restriction sites anddetailed guidelines for selecting restriction enzymes and designing primers. The amplified product was efficiently cloned into plasmids, and sequencing analysis was performed using free web-based tools. Successful cloning was then confirmed by expressing the gene in murine target cells¹⁰.

Topoisomerase-based (TOPO) cloning

Mechanism underlying topoisomerase-based cloning (TOPO):
TOPO cloning leverages topoisomerase I to clone DNA fragments into the vector. Unlike restriction-enzyme cloning, TOPO cloning does not require restriction enzymes; instead, topoisomerase I creates sticky ends that facilitate the insertion of DNA, which usually contains 3ʹ A overhangs, into the cloning vector (which contains T overhangs)⁶.

Benefits and uses of genetic research:
TOPO cloning is a fast, simple, and efficient cloning process. It is ideal for inserting PCR products quickly and accurately into the desired vector. This method is beneficial for cloning high-fidelity PCR products and when fast cloning is required. However, it is limited by the insert size, which is usually 2–3 kb, and the available vector choices⁶.

Example: Vaccinia topoisomerase I (TOPO) cloning enables quick insertion of PCR products into mammalian‑expression vectors like pcDNA3.1, streamlining cDNA expression studies¹¹.

Advanced cloning techniques

Overview of Gibson assembly and Golden Gate cloning:

Gibson assembly, Golden Gate cloning, and the gateway system are advanced, precise methods for assembling multiple DNA fragments into a single recombinant construct⁸. Gibson assembly uses enzymes such as T5 exonuclease, DNA polymerase, and ligase to join fragments with overlapping regions⁸.

Advantages: It streamlines cloning by using fewer steps and reagents than traditional methods, achieving rapid, scar‑free constructs¹².

Limitations: It needs long (≥ 40 bp) overlap primers that raise synthesis costs, and the sequence‑specific overlaps generally tie each PCR product to insertion into only a single destination vector¹³.

Golden gate cloning employs Type IIS restriction enzymes, which cleave DNA outside the recognition sites, creating custom overhangs for precise ligation.

Advantages: It efficiently assembles multiple DNA fragments seamlessly in a single reaction¹⁴.

Limitations: It faces challenges like the limited availability of Type IIS restriction enzymes. Additionally, it demands pre‑engineering matching Type IIS restriction sites into both the vector and the DNA insert¹³.

The gateway system uses the phage lambda site-specific recombination system to enable easy transfer of DNA segments between various expression platforms. This method ensures correct orientation and reading frame, making it ideal for high-throughput applications.

Advantages: This cloning system improves traditional cloning by offering greater adaptability, efficiency, and compatibility.

Limitations: It is constrained by proprietary Clonase enzymes and recognition sites, it demands costly kits and pre‑existing att sequences in both vector and insert¹³.

Applications and benefits of advanced cloning methods:

• Advanced cloning techniques are widely used in synthetic biology and gene synthesis for assembling large, multi-fragment constructs.
• They enable high-throughput cloning, the assembly of gene clusters, and precise control over DNA fragment orientation.
• By facilitating multiple fragments to be assembled in a single step, these methods are efficient and highly beneficial for advanced genetic research and the construction of complex biological systems.

Tools and components used in molecular cloning

Molecular cloning substantially relies on restriction enzymes, ligases, and topoisomerases^15,16.

Restriction enzymes

These enzymes cleave DNA at specific recognition sites. There are two main types: exonucleases and endonucleases. Exonucleases remove terminal nucleotides from the DNA, while endonucleases, such as EcoRI and HindIII, cut DNA internally at specific sequences, creating either sticky or blunt ends. The four types of restriction enzymes are^9,17:

• Type I restriction enzyme: First discovered in E. coli as DNA‑entry barriers, are large oligomeric enzymes encoded by three hsd genes: hsdR (restriction), hsdM (modification), and hsdS (specificity).
• Early genetic and antibody studies grouped these enzymes into several related families—Type IA, IB, IC, later ID and IE—based on shared subunit interactions and sequence homology. For example, EcoKI, and EcoBI derived from E.coli. Similar family groupings now extend beyond enteric bacteria, such as distinct Type I systems found in Staphylococcus aureus and other species.
• Type II restriction enzymes: Cleave DNA at specific positions relative to their recognition sites, generating characteristic fragment patterns on gels. Classic Type II enzymes like EcoRI are homodimers that recognize palindromic sequences and cut within them, relying on Mg²⁺ and partnering in vivo with separate methyltransferases. Examples include HindIII and EcoRI, which are Type IIP enzymes that cut symmetrically within palindromic sites. BcgI spans several subgroups, recognizing an asymmetric site (IIA), and cutting on both sides (IIB). DpnI is both Type IIM (active only on methylated G m6ATC) and Type IIP due to its palindromic, internal cleavage.
• Type III restriction enzymes: Carries the properties of both Types I and II. They recognize asymmetric DNA sequences, cut 25–27 bp from the site, and may require ATP and S‑adenosyl‑methionine (SAM). EcoP1I and EcoP15I are two examples of type III restriction enzymes.
• Type IV restriction enzyme: Modification‑dependent (Type IV) restriction systems were first revealed when unglucosylated T4 phage DNA containing hydroxymethylcytosine (hm⁵C) was restricted by E. coli K‑12 but could grow in Shigella dysenteriae, which lacks the relevant endonucleases and protective glucosylation pathway. Because Type IV nucleases discriminate among cytosine variants (C, m⁵C, hm⁵C, etc.), they are valuable probes for studying DNA methylation and other epigenetic phenomena.

DNA ligase

It is another essential enzyme that catalyzes the formation of phosphodiester bonds, joining the ends of two DNA strands. It requires a free 3ʹ-hydroxyl group and a 5ʹ-phosphate group to facilitate this bond. DNA ligase is vital for repairing DNA breaks and creating recombinant DNA molecules, as it seals nicks in the DNA backbone.

DNA ligases fall into two main classes: ATP‑dependent enzymes found in eukaryotes, viruses, and archaea, and NAD⁺‑dependent enzymes unique to bacteria. While ATP‑ligases vary widely in size, bacterial NAD⁺‑ligases are homologous 70–80 kDa monomers¹⁸.

For example, T4 bacteriophage DNA ligase specializes in sealing single‑strand nicks within double‑stranded DNA. However, it has not evolved to join separate double‑stranded fragments with sticky or blunt ends¹⁹.

Cloning vectors (plasmids, cosmids, bacterial artificial chromosomes [BACs], and yeast artificial chromosomes [YACs])

Cloning vectors are DNA molecules that deliver foreign genetic material into host cells.

Plasmids, small circular DNA found naturally in bacteria, were the first vectors used in molecular cloning. They are highly efficient, easy to manipulate, and can carry up to 10 kb of DNA. pCEP4, for example, is a commercially available Epstein-Barr virus (EBV) vector plasmid, which contains Ori P and EBNA-1, genes that play an essential role in maintaining the plasmid as an episome²⁰.

The presence of an antibiotic selection marker, such as hygromycin, allows for the selection of cells that retain the plasmid without its chromosomal integration. This EBV-based vector supports low transgene expression, maintaining around 20–100 copies per cell, making it valuable for various gene expression studies.

Cosmids combine the advantages of plasmids and bacteriophages by carrying large DNA inserts (up to 45 kb) and facilitating their packaging into phage particles for easy transfer into bacteria. This approach has been instrumental in gene discovery, as demonstrated by the identification of the anisomycin biosynthetic gene cluster (BGC) from Streptomyces hygroscopicus by using a bioactivity-guided high-throughput screening of a cosmid library.

Bacterial artificial chromosomes (BACs) can accommodate large DNA inserts (150–350 kb) to be cloned in bacteria such as E.coli and are ideal for cloning extensive genomic regions. After a BAC carrying an organism’s genomic segment is introduced into the bacterium, normal cell division replicates and amplifies the recombinant BAC DNA. The purified BAC clones provide abundant, stable templates for downstream applications, most notably large‑scale DNA sequencing projects²¹.

A notable example is the isolation of the biosynthetic gene cluster (BGC) for antifungal neotetrafibricin (I-NTF) from Streptomyces rubrisoli using a BAC library with a 200 kb insert size. The biosynthetic pathway of I-NTF was further elucidated through heterologous expression, demonstrating the utility of BACs in functional genomics²².

Yeast artificial chromosomes (YACs) are used to clone DNA within yeast cells, supporting inserts up to 200 kb. These vectors facilitate the study of eukaryotic chromosomes by preserving the structural and functional integrity of large genomic regions. YACs have been widely used to clone extensive genomic loci, enabling the analysis of complex genes and regulatory elements. Their ability to maintain large DNA sequences makes them indispensable in genomic research and chromosome engineering.

Selection markers and their importance

Selectable markers are vital for identifying cells that have successfully incorporated the recombinant DNA. These markers commonly include antibiotic resistance genes, which enable the selective growth of transformed cells while eliminating non-transformed ones. Without selection markers, it would be highly challenging to distinguish between transformed and non-transformed cells, significantly reducing cloning efficiency.

One common selectable marker is the ampicillin resistance gene (bla), which encodes the enzyme β-lactamase. This enzyme hydrolyzes the β-lactam ring of ampicillin, deactivating the antibiotic and allowing bacterial growth in its presence. The bla gene is frequently incorporated into plasmid vectors, ensuring the survival and propagation of successfully transformed bacterial cells in selective media²³.

Applications for molecular cloning

There are numerous applications for molecular cloning. Some are outlined below²⁴:

Research applications: Gene function studies and genetic research

Molecular cloning enables the amplification and analysis of individual genes, providing insights into their functions and roles in both normal physiology and disease states. Researchers can study gene regulation, interactions, and their effects on phenotypic traits by expressing cloned genes in various model organisms. . This approach is essential for understanding complex genetic disorders and identifying potential therapeutic targets.

Advancements in cloning techniques have significantly accelerated the development of gene therapy vectors and recombinant protein production. These innovations facilitate the in vitro synthesis of custom DNA constructs, which play a vital role in the design of novel vaccines and therapeutic strategies. Molecular cloning continues to be a powerful tool in biomedical research, driving discoveries in genetic engineering, drug development, and precision medicine.

Medical applications

Molecular cloning also plays a central role in developing diagnostic tools such as PCR-based tests and in producing therapeutic proteins, including insulin, for diabetes treatment. It has transformed the production of monoclonal antibodies, which serve as essential treatments for cancer, autoimmune diseases, and infections.

Gene therapy, a promising approach for sickle cell disease (SCD), uses molecular cloning to address the single-point mutation affecting hemoglobin. Gene-addition strategies utilizing optimized gene transfer vectors aim to enhance the expression of normal or antisickling globins, offering a potential cure by reducing disease symptoms.

Protein production

The mass production of proteins for both medical and industrial purposes is facilitated by molecular cloning. For example, human insulin is now produced in bacteria or yeast through recombinant DNA technology, replacing the need for animal-derived insulin.

Similarly, therapeutic antibodies for immunotherapy are produced using cloned genes. Adalimumab is the firstfully human therapeutic antibody targeting tumor necrosis factor α (TNFα). The U.S. FDA approved it in 2002 as a primary cancer treatment, although it was initially approved for treating rheumatoid arthritis²⁵.

Development of genetically modified organisms (GMOs)

In agriculture, molecular cloning is used to develop genetically modified organisms (GMOs) with beneficial traits such as enhanced disease resistance, higher yields, and better nutritional value, addressing global food security challenges. A notable example is the genetically modified (GM) papaya, engineered for resistance to papaya ringspot virus (PRSV). Approximately 90% of papayas grown in Hawaii contain the PRSV coat protein gene, significantly improving crop yield and disease resistance²⁶.

Although concerns exist regarding biosafety and potential health risks, rigorously tested GM crops are considered safe for consumption. Integrating modern biotechnology with sustainable agricultural practices offers a promising approach to ensuring global food security for future generations.

Contributions to drug discovery and biotechnology

Drug discovery has been considerably accelerated thanks to molecular cloning by enabling the production of biologically active molecules and supporting biotechnological applications such as bioprocessing such as human insulin in E. coli²⁷, enzyme production such as α‑Amylase in Bacillus subtilis²⁸, and bio-based material development such as poly‑3‑hydroxybutyrate (PHB) in E. coli²⁹.Streptomyces bacteria, studied for over 80 years, are known for their unique fungal-like developmental cycle and for producing a diverse range of antibiotics and specialized metabolites³⁰.

Recent advancements have simplified recombinant protein expression in Saccharomyces cerevisiae, requiring fewer steps for gene transformation and plasmid transfer. This streamlined approach enhances high-throughput studies, facilitating faster drug discovery and biotechnological research.

Applications in environmental science

Molecular cloning is increasingly applied in environmental science to monitor, remediate, and understand ecosystems at the molecular level. Engineered microbes or plants cloned with key mer operon genes (especially merA and merB) offer a low‑cost, eco‑friendly way to convert toxic mercury into harmless vapor³¹. This helps in reducing mercury pollution. Another such example is the molecular cloning of the AtACR2 gene into tobacco to create arsenic-tolerant plants that grow on high arsenate levels. These transgenic plants store less arsenic in their shoots and more in their roots, reducing toxicity. This shows how cloning can develop crops that clean contaminated soils and produce safer food³².

Challenges and troubleshooting in molecular cloning

Despite having several advantages, molecular cloning faces lots of difficulties. Some have been elaborated upon below¹:

Common challenges

Successful molecular cloning can be hindered by obstacles like vector compatibility and low cloning efficiency. Plasmid vectors may not integrate effectively into host cells, and cloning attempts can sometimes lead to the insertion of unwanted sequences. Additionally, the choice of cloning techniques, whether traditional restriction enzyme-based methods or more advanced approaches like CRISPR-based cloning, can significantly impact the outcome, depending on the specific objectives of the experiment.

Strategies for troubleshooting

Common troubleshooting strategies in molecular cloning include addressing contamination, which, when resolved, helps prevent the growth of unwanted microorganisms. Improving experimental conditions, such as optimizing DNA concentration and using high-quality enzymes, can also enhance cloning efficiency and yield. Additionally, evaluating and refining vector systems and cloning protocols are crucial for increasing the overall success rate of the cloning process.

Tips for a successful cloning experiment

• Using high-quality enzymes helps ensure accurate DNA isolation and amplification while minimizing errors.
• Carefully ligating DNA fragments into vectors increases the chances of successful recombination.
• Verifying insert orientation through sequencing confirms that the gene of interest is correctly integrated.
• Implementing proper controls at each step helps validate results and catch potential issues early.
• Optimizing transformation conditions improves how efficiently host cells take up recombinant DNA.
• Choosing the right host organism is key to ensuring effective DNA expression and replication.

Advances and future directions in molecular cloning

Molecular cloning has experienced dramatic changes over time, transitioning from cloning a single DNA fragment to assembling multiple DNA fragments into a continuous stretch of DNA. It continues to evolve with the advent of new technologies.

Recent advancements

Innovations such as CRISPR-Cas9 gene-editing technology have drastically improved the precision and efficiency of molecular cloning. CRISPR allows for targeted modifications of specific genes, offering substantial control and few off-target effects³³.

Additionally, automation in cloning processes, including high-throughput sequencing and robotic handling, promises to reduce labor and increase throughput. Automated pipetting workstations and integrated equipment have streamlined repetitive tasks. This reduces manual labor and improves efficiency in synthetic biology. Advancements in oligonucleotide synthesis, automated DNA assembly, and biofoundries (a combination of automation and biomanufacturing) offer new opportunities and challenges in achieving accurate, high-throughput DNA synthesis and assembly³⁴.

Potential applications of emerging cloning technologies

Future applications could include more refined gene therapies for genetic disorders, advanced crop engineering, and a better understanding of gene-environment interactions. For example, CRISPR-Cas9 technology has been used to edit milk allergen genes in dairy cows and goats to get better yields. Another example includes the use of CRISPR-Cas9 to delete a mutation in the CEP290 gene responsible for Leber congenital amaurosis type 10 (LCA10), a severe retinal dystrophy caused by aberrant splicing^35,36.

Synthetic biology could push these advancements even further, making it possible to design entirely new organisms with custom genetic frameworks. One example is GoldenBraid cloning, a system originally developed for plant genetic engineering that has since been adapted for amoebas, such as Dictyostelium discoideum, human cell lines, fungi, and yeast mitochondria. This method relies on type IIS restriction enzymes such as BsmBI and BsaI, which cut just outside their recognition sites, creating user-defined sticky ends that improve cloning efficiency. By integrating standardized vector backbones with strategically placed restriction sites, GoldenBraid enables one-pot reactions, where digestion, restriction, and ligation occur simultaneously, streamlining the cloning process and enhancing precision.

Challenges and opportunities for the future

Although molecular cloning holds excellent promise, challenges remain in terms of ethical concerns, public acceptance, and regulatory oversight. Opportunities lie in improving the efficiency and specificity of gene-editing tools and enhancing the scalability of biotechnological applications, particularly in drug discovery and environmental sustainability.

FAQs

How does TOPO cloning differ from traditional molecular cloning techniques?

TOPO cloning differs from traditional methods by including the use of topoisomerase I for direct ligation of PCR products into vectors, bypassing the need for restriction enzymes and specific recognition sites. This makes TOPO cloning faster, simpler, and more efficient, especially for small DNA inserts (2–3 kb). In contrast, traditional cloning requires restriction enzyme digestion and ligation, which can be more time-consuming. TOPO cloning is ideal for quick cloning, while conventional methods handle larger fragments and complex constructs better.

What are the advantages of using PCR cloning over other methods?

PCR cloning is the process of creating multiple copies of a given DNA segment using an enzyme known as DNA polymerase. This approach can produce hundreds of millions of DNA molecules in hours, making it far more efficient than cloning expressed genes. PCR cloning, unlike other techniques, does not require a host organism to propagate the DNA, and can clone even small or rare DNA sequences. Furthermore, PCR cloning is so versatile that specific sequences (such as restriction sites or tags) can be added to target DNA, increasing the flexibility and precision of cloning operations.

What are some common applications of molecular cloning in clinical microbiology?

Recent advancements in molecular cloning have had a significant impact on clinical microbiology, particularly in addressing polymicrobial infections and creating recombinant therapeutic agents. Traditional culture-based methods for identifying polymicrobial infections have limitations; however, cloning technologies have overcome these challenges, offering more precise diagnostic tools. Recombinant antigens produced via cloning are now used to screen infections caused by microorganisms such as HIV, HCV, HBV, CMV, and Treponema pallidum.

Additionally, recombinant vaccines for diseases such as hepatitis B, cholera, and influenza A have replaced live vaccines, lowering the risk of adverse effects. Cloning also plays a vital role in developing gene probes used in early diagnosis of genetic disorders, forensic analysis, and routine diagnostic tests. Furthermore, this technology has enabled the production of antimicrobial peptides and recombinant cytokines, which show promise as new therapeutic options.

References

1. Bertero, A., Brown, S., Vallier, L. Methods of cloning. Basic Science Methods for Clinical Researchers. 19-39 (2017).
2. Sharma, K., Mishra, A. K., Mehraj, V., et al. Advances and Applications of Molecular Cloning in Clinical Microbiology. Biotechnology & Genetic Engineering Reviews. 30(1‑2), 65–78 (2014).
3. Wang, B., Li, J. Understanding the Molecular Bases of Agronomic Trait Improvement in Rice. The Plant Cell. 31(7), 1416–1417 (2019).
4. Yoshida, S., Hiraga, K., Taniguchi, I., et al. Ideonella sakaiensis, PETase, and MHETase: From identification of microbial PET degradation to enzyme characterization. ScienceDirect. 648, 187–205 (2021).
5. Julin, D. Blue‑White Selection. Molecular Life Sciences. 1–2, (2014).
6. Clark, D. P., Pazdernik, N. J., McGehee, M. R. Cloning genes for synthetic biology. Molecular Biology. 199-239 (2019).
7. Fischer, M. D., Mgboji, E., Liu, Z. Pyrite cloning: a single tube and programmed reaction cloning with restriction enzymes. Plant Methods. 14(1), (2018).
8. Sorida, M., Bonasio, R. An efficient cloning method to expand vector and restriction site compatibility of Golden Gate Assembly. Cell Reports Methods. 3(8), 100564–4 (2023).
9. Loenen, W. A. M., Dryden, D. T. F., Raleigh, E. A., et al. Highlights of the DNA cutters: a short history of the restriction enzymes. Nucleic Acids Research. 42(1), 3–19 (2013).
10. Hoseini, S., Sauer, M. G. Molecular cloning using polymerase chain reaction, an educational guide for cellular engineering. Journal of Biological Engineering. 9(1), 2 (2015).
11. Udo, H. An alternative method to facilitate cDNA cloning for expression studies in mammalian cells by introducing positive blue white selection in vaccinia topoisomerase I-mediated recombination. PLOS ONE. 10(9), (2015).
12. Thomas, S., Maynard, N. D., Gill, J. DNA library construction using Gibson Assembly®. Nature Methods. 12(11), (2015).
13. Katzen, F. Gateway® recombinational cloning: a biological operating system. Expert Opinion on Drug Discovery. 2(4), 571–589 (2007).
14. Biró, J. B., Kecskés, K., Szegletes, Z., et al. Golden EGG, a simplified Golden Gate cloning system to assemble multiple fragments. Scientific Reports. 14(1), (2024).
15. Mandal, A. Unit 2, Molecular Cloning Tools and Strategies.
16. Alberts, B., Johnson, A., Lewis, J., et al. Isolating, Cloning, and Sequencing DNA. National Library of Medicine. Garland Science. (2002).
17. Loenen, W. A. M., Dryden, D. T. F., Raleigh, E. A., Wilson, G. G. Type I restriction enzymes and their relatives. Nucleic Acids Research. 42(1), 20–44 (2014).
18. Doherty, A. J. Structural and mechanistic conservation in DNA ligases. Nucleic Acids Research. 28(21), 4051–4058 (2000).
19. Wilson, R. H., Morton, S. K., Deiderick, H., et al. Engineered DNA ligases with improved activities in vitro. Protein Engineering Design and Selection. 26(7), 471–478 (2013).
20. Ryu, W.S. Virus Vectors. Molecular Virology of Human Pathogenic Viruses. 263–275 (2017).
21. Bacterial Artificial Chromosome (BAC). Genome.gov. (2024).
22. Park, H. S., Park, J. H., Kim, H. J., et al. BAC cloning and heterologous expression of a giant biosynthetic gene cluster encoding antifungal neotetrafibricin in Streptomyces rubrisoli. Frontiers in Bioengineering and Biotechnology. 10, (2022).
23. Kong, K. F., Schneper, L., Mathee, K. Beta-lactam antibiotics: from antibiosis to resistance and bacteriology. APMIS. 118(1), 1–36 (2010).
24. Datta, N. Unlocking the power of molecular cloning: revolutionizing medical microbiology procedures. University of Michigan Undergraduate Research Journal. 17, (2024).
25. Lu, R.M., Hwang, Y.C., Liu, I.J., et al. Development of therapeutic antibodies for the treatment of diseases. Journal of Biomedical Science. 27(1), 1–30 (2020).
26. Davidson, S. N. Forbidden Fruit: Transgenic Papaya in Thailand. Plant Physiology. 147(2), 487–493 (2008).
27. Riggs, A. D. Making, Cloning, and the Expression of Human Insulin Genes in Bacteria: The Path to Humulin. Endocrine Reviews. 42(3), (2020).
28. Palva, I. Molecular cloning of α‑amylase gene from Bacillus amyloliquefaciens and its expression in B. subtilis. Gene. 19(1), 81–87 (1982).
29. Jiang, N., Wang, M., Song, L., et al. Polyhydroxybutyrate production by recombinant Escherichia coli based on genes related to synthesis pathway of PHB from Massilia sp. UMI-21. Microbial Cell Factories. 22(1), (2023).
30. Schlimpert, S., Elliot, M.A. The best of both worlds—Streptomyces coelicolor and Streptomyces venezuelae as model species for studying antibiotic production and bacterial multicellular development. Journal of Bacteriology. 205(7), (2023).
31. The Open Biotechnology Journal - Volume 12. Openbiotechnologyjournal.com. (2018).
32. Nahar, N., Rahman, A., Nawani, N. N., et al. Phytoremediation of arsenic from the contaminated soil using transgenic tobacco plants expressing ACR2 gene of Arabidopsis thaliana. Journal of Plant Physiology. 218, 121–126 (2017).
33. Adli, M. The CRISPR tool kit for genome editing and beyond. Nature Communications. 9(1), 1911 (2018).
34. Ma, Y., Zhang, Z., Jia, B., et al. Automated high-throughput DNA synthesis and assembly. Heliyon. 10(6), e26967–7 (2024).
35. Tara, A., Singh, P., Gautam, D., et al. CRISPR-mediated editing of β-lactoglobulin (BLG) gene in buffalo. Scientific Reports. 14(1), (2024).
36. Brackett, N.F., Pomés, A., Chapman, M.D. New frontiers: precise editing of allergen genes using CRISPR. Frontiers in Allergy. 2, (2022).